Scheinhorn D J, Angelillo V A
West J Med. 1977 Sep;127(3):195-8.
A total of 1,939 reported births to mothers who received isoniazid ethambutol, rifampin and streptomycin alone or in combination, for all or part of their pregnancies, were surveyed to determine teratogenicity of these agents. There was no significant increase in birth defects with isoniazid, ethambutol and rifampin, in contrast to the use of streptomycin which was associated with mild auditory and vestibular defects. Guidelines for the treatment of active tuberculosis in pregnancy are therefore established.
共对1939名在孕期全部或部分时间单独或联合使用异烟肼、乙胺丁醇、利福平及链霉素的母亲所分娩的婴儿进行了调查,以确定这些药物的致畸性。与链霉素使用相关的轻度听觉和前庭缺陷不同,异烟肼、乙胺丁醇和利福平并未导致出生缺陷显著增加。因此制定了孕期活动性肺结核的治疗指南。